Drugs / Human Dopaminergic Progenitor Cells
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT07289477 | Jan 2026 → Oct 2027 expected | multiple system atrophy, parkinsonian type | iRegene Therapeutics Co., Ltd. | Recruiting | No outcome recorded |
| Phase 1 | NCT06608355 | Aug 2024 → Apr 2026 overdue | Parkinson disease | iRegene Therapeutics Co., Ltd. | Recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT07102342 | Jan 2026 → Sep 2027 expected | Parkinson disease | iRegene Therapeutics Co., Ltd. | Recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07028632 | Jun 2025 → Dec 2026 expected | Parkinson disease | iRegene Therapeutics Co., Ltd. | Not yet recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2025-10-13 | iRegene Therapeutics Co., Ltd. | Results 睿健医药受邀在MDS报告NouvNeu001开创性研究进展 iregene.com ↗
此外，受试者大群体层面的成熟神经元PET影像结果也进一步证实了NouvNeu001移植后在I期受试者大群体脑部的长期存活与稳定分化整合的优异能力。 |
| 2024-06-24 | iRegene Therapeutics Co., Ltd. | Regulatory 再下一城，睿健NouvNeu001 IND获得FDA批准开展海外临床 iregene.com ↗
美国时间6月20日，美国食品药品监督管理局（FDA）正式批准了睿健医药帕金森管线NouvNeu001的IND申请。 |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2025-10-13 | iRegene Therapeutics Co., Ltd. | 睿健医药受邀在MDS报告NouvNeu001开创性研究进展 iregene.com ↗ |
| 2024-06-24 | iRegene Therapeutics Co., Ltd. | 再下一城，睿健NouvNeu001 IND获得FDA批准开展海外临床 iregene.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Dopaminergic Progenitor Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06608355 ↗ |
| Modality | Cell therapy | “This clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells...” NCT07289477 ↗ |
| Route | Other | “Single injection of Human Dopaminergic Progenitor Cells into the putamen of brain.” NCT06608355 ↗ |